Triple-negative breast cancer (TNBC) is an aggressive histological subtype of breast cancer characterized by the lack of estrogen receptor (ER), progesterone receptor (PR), and lack of amplification/overexpression of human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and breast carcinoma.